Rezaei, Y and Arjmand, N (2016) Letter by Rezaei and Arjmand Regarding Article, “Cerebrolysin and Recovery After Stroke (CARS): A Randomized, PlaceboControlled, Double-Blind, Multicenter Trial”. Stroke, 47. p. 90.
|
Text
355.pdf Download (505kB) | Preview |
Abstract
We read with great interest and appreciation the article by Muresanu et al1 on the effects of cerebrolysin on the improvement of motor function in patients with acute ischemic stroke. Within the word count limitations of this letter, however, we would like to present a point that needs to be addressed and evaluated more in future experimental and clinical studies regarding the cerebrolysin mechanisms of action to improve ischemic stroke outcomes. Cerebrolysin is a neuroprotective medication, which is a porcine brain–derived peptide that acts as a neurotrophic agent similar to growth and neurotrophic factors in the brain. It has been postulated that cerebrolysin implements its effect through the inhibition of apoptosis and
| Item Type: | Article |
|---|---|
| Subjects: | R Medicine > R Medicine (General) |
| Depositing User: | Unnamed user with email gholipour.s@umsu.ac.ir |
| Date Deposited: | 08 Oct 2018 08:14 |
| Last Modified: | 30 Jun 2019 03:40 |
| URI: | http://eprints.umsu.ac.ir/id/eprint/5174 |
Actions (login required)
 |
View Item |
